查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1486840

输液治疗设备的全球市场 - 市场分析、竞争格局、市场预测（2030 年）

Infusion Therapy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

到2030年，全球输液治疗设备市场规模预计将达到776.5亿美元，2024-2030年预测期间复合年增长率为6.56%。输液治疗设备的需求激增主要是由于糖尿病和癌症等慢性病盛行率的上升所推动的。输液治疗设备涵盖了广泛的临床治疗领域，市场呈现显着成长，产品投放数量显着增加。这些因素共同促进了输液治疗设备市场在 2024-2030 年预测期内的成长轨迹。

输液治疗设备市场动态

世界各地的糖尿病和癌症流行正在推动输液治疗设备市场的显着成长。根据国际糖尿病联盟（IDF）估计，到 2021 年，预计将有 5.37 亿 20 岁至 79 岁之间的成年人患有糖尿病。预计到 2030 年，这一数字将增至 6.43 亿，到 2045 年将增至 7.83 亿。此外，据报导有 5.41 亿人存在糖耐受性受损 (IGT)，这使他们患 2 型糖尿病的风险增加。值得注意的是，四分之三的成人糖尿病患者生活在低收入和中等收入国家，这些国家对胰岛素帮浦等先进医疗设备的需求非常高。这些医疗设备对于持续、准确地施用胰岛素至关重要，对于有效的血糖管理也至关重要。

美国癌症协会发布的癌症统计数据也推动了对输液治疗设备的需求。 2020年，预计全球将出现1,930万新发癌症病例，其中不包括1,810万例非黑色素瘤皮肤癌。乳癌占新发病例的 11.7%，超过肺癌（11.4%），使其成为最常诊断的癌症。在其他癌症中，最常见的是大肠直肠癌（10.0%）、摄护腺癌（7.3%）和胃癌（5.6%）。输液治疗对于化疗至关重要，进一步强调了这些设备在癌症治疗中的重要作用。

输液治疗设备市场也受惠于产业公司之间不断增加的联盟和合作关係。例如，2023年8月，芬兰医疗技术公司Monidor Oy与国际领先医疗设备製造商贝朗公司合作，加强远距输液治疗监测。像这样的合作关係对于推进输液治疗领域至关重要。

另一个重大进展是，Eitan Medical 于 2021 年 4 月宣布推出革命性的互联多疗法门诊输液系统 Avoset。凭藉其紧凑的设计和远端监控功能，Avoset 旨在改变急性后护理和专业输液治疗，提高患者安全和使用者体验。

儘管存在这些积极趋势，但市场仍面临课题，例如输液治疗设备的高成本以及与其使用相关的感染风险。这些因素可能会限制 2024-2030 年预测期间的市场成长。然而，由于有效管理糖尿病和癌症等慢性病的需求不断增长，预计输液治疗设备市场的整体扩张将持续。

输液治疗设备市场区隔分析

注射器输液帮浦预计将在 2023 年占据输液治疗设备市场的主要收入占有率。注射器输液帮浦（注射器驱动器）以其精确性而闻名，对于将少量液体（例如药物和营养物质）直接注入患者的血液中至关重要。

注射器输液帮浦具有多重优点，使其在临床实务中不可或缺。这些设备用途广泛，专为便携式和固定用途而设计，并包括用于温度控制的内部加热器。此功能对于注射需要特定温度设定以保持有效性的输注液特别有益。此外，注射帮浦可以与电脑交互，允许医疗保健提供者对设备进行编程，以提高准确性并追踪输液历史，从而最大限度地减少出错的可能性。

本报告研究和分析了全球输液治疗设备市场，提供市场规模和预测、驱动因素和课题、公司和产品概况等。

目录

第一章输液治疗设备市场报告简介

第二章输液治疗设备市场执行摘要

  • 市场概览

第三章竞争态势

第 4 章监理分析

  • 美国
  • 欧洲
  • 日本
  • 中国

第五章输液治疗设备市场主要因素分析

  • 推动输液治疗设备市场的因素
  • 输液治疗设备市场的限制与课题
  • 输液治疗设备市场机遇

第六章波特输液治疗设备市场五力分析

第七章输液治疗设备市场评估

  • 依产品类型
    • 注射器输液泵
    • 大容量帮浦（LVP）
    • 弹性体泵
    • 其他
  • 可移动性别
    • 便携式输液泵
    • 固定式输液泵
  • 依用途
    • 多发性硬化症
    • 糖尿病
    • 类风湿性关节炎
    • 癌症
  • 最终用户
    • 医院、诊所
    • 门诊手术中心
    • 居家护理
  • 依地区
    • 北美
    • 欧洲
    • 亚太地区
    • 其他领域

第八章输液治疗设备市场公司及产品概况

  • Fresenius Kabi AG
  • Ossila
  • Ace-medical
  • ICU Medical
  • Chmyx inc.
  • Mindray
  • Baxter
  • Becton, Dickinson and Company
  • Micrel Medical Devices SA
  • AKAS Infusions
  • Narang Medical Limited
  • Monidor Oy.
  • Smiths Group plc.
  • B. Braun SE
  • Trivitron Healthcare
  • Eitan Medical

第9章KOL浏览量

第 10 章专案方法

第 11 章关于 DelveInsight

第 12 章免责声明，联络我们

Product Code: DIMDCL0707

Infusion Therapy Devices Market By Product Type (Syringe Infusion Pumps, Large Volume Pumps, Elastomeric Pumps, And Others), Mobility (Portable Infusion Pumps, And Stationary Infusion Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, And Others), End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Homecare And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to rise in the prevalence of chronic disorders and increasing clinical applications of infusion therapy devices

The global Infusion Therapy Devices market is estimated to grow at a CAGR of 6.56% during the forecast period from 2024 to 2030 to reach USD 77.65 billion by 2030. The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy devices market throughout the forecast period spanning from 2024 to 2030.

Infusion Therapy Devices Market Dynamics:

The global prevalence of diabetes and cancer is driving significant growth in the market for infusion therapy devices. According to the International Diabetes Federation (IDF), in 2021, an estimated 537 million adults aged 20-79 were living with diabetes. This number is projected to rise to 643 million by 2030 and 783 million by 2045. Additionally, 541 million individuals were reported to have Impaired Glucose Tolerance (IGT), putting them at high risk of developing Type 2 diabetes. Notably, three-quarters of adults with diabetes reside in low- and middle-income countries, where the need for advanced medical devices like insulin pumps is crucial. These devices are essential for continuous and precise insulin delivery, and vital for effective blood sugar management.

The demand for infusion therapy devices is also bolstered by the cancer statistics published by the American Cancer Society. In 2020, there were an estimated 19.3 million new cancer cases worldwide, excluding 18.1 million cases of non-melanoma skin cancer. Breast cancer has emerged as the most commonly diagnosed cancer, comprising 11.7% of new cases, surpassing lung cancer, which accounts for 11.4% of cases. The other prevalent cancers include colorectal (10.0%), prostate (7.3%), and stomach (5.6%). Infusion therapy is integral to chemotherapy delivery, further underscoring the critical role of these devices in cancer treatment.

The infusion therapy devices market is also benefiting from increased collaborations and partnerships among industry players. For instance, in August 2023, Monidor Oy, a Finnish health technology company, partnered with B. Braun, a leading international medical device manufacturer, to enhance remote IV therapy monitoring. Such partnerships are pivotal in advancing the field of infusion therapy.

In another significant development, Eitan Medical introduced a groundbreaking connected multi-therapy ambulatory infusion system, Avoset, in April 2021. Avoset is designed to transform post-acute care and specialized infusion therapy with its compact design and remote monitoring capabilities, enhancing patient safety and user experience.

Despite these positive trends, the market faces challenges such as the high cost of infusion therapy devices and the risk of infection associated with their use. These factors may restrain market growth during the forecast period of 2024 to 2030. However, the overall expansion of the infusion therapy device market is expected to continue, propelled by the rising need to manage chronic diseases like diabetes and cancer effectively.

Infusion Therapy Devices Market Segment Analysis:

Infusion Therapy Devices Market by Product Type (Syringe Pumps, Large Volume Pumps (LVP), Elastomeric Pumps, and Others), Mobility (Portable Infusion Pumps, and Stationary Pumps), Application (Multiple Sclerosis, Diabetes, Rheumatoid Arthritis, Cancer, and Others), End-User (Hospitals and Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

The syringe infusion pump segment is poised to capture a substantial revenue share of the infusion therapy devices market in 2023. Known for their precision, syringe infusion pumps, or syringe drivers, are crucial for administering small volumes of fluids, such as medications or nutrients, directly into a patient's bloodstream.

Syringe infusion pumps offer several advantages, making them indispensable in clinical settings. These devices are versatile, designed for both portable and stationary use, and incorporate an internal heater for temperature control. This feature is particularly beneficial for administering fluids that require specific temperature settings to maintain efficacy. Furthermore, syringe pumps can interface with computers, allowing healthcare providers to program the device for enhanced accuracy and to track the history of infusions, minimizing the potential for errors.

The capability to deliver fluids with higher viscosity is another notable benefit. These pumps can operate continuously for up to 24 hours, ensuring that patients receive a consistent and precise dosage of medication over a specified period. They also allow for the mixing and administering of multiple medications simultaneously, significantly reducing the need for frequent injections and improving patient comfort.

The demand for syringe infusion pumps is expected to grow due to their ability to deliver an accurate dosage over extended periods, which is increasingly essential in both acute and chronic care settings. This growth is further supported by the introduction of new and innovative products that have received regulatory approvals. For example, in August 2021, Baxter's Novum IQ syringe infusion pump received FDA 510(k) clearance. This device enhances the infusion process with advanced safety features, improved connectivity, configurable anesthesia care settings, and a user-friendly interface, emphasizing precision and reliability in medication delivery.

Given these developments, the syringe infusion pump segment is anticipated to experience notable growth, significantly contributing to the expansion of the overall infusion therapy device market from 2024 to 2030.

North America Is Expected To Dominate The Overall Infusion Therapy Devices Market:

North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

According to 2023 data from the Centers for Disease Control and Prevention (CDC), approximately 53.2 million people, or one in five U.S. adults, had doctor-diagnosed arthritis between 2019 and 2021. Arthritis is more prevalent among women (20.9%) than men (16.3%), and the likelihood of developing the condition increases with age. Notably, the prevalence of arthritis is higher among those with no leisure-time physical activity (30.9%) compared to those who are somewhat active (27.0%) or meet physical activity recommendations (18.8%). For individuals with arthritis where oral medications are ineffective, infusion therapy serves as a vital alternative, offering direct and rapid delivery of medication into the bloodstream.

The market is also stimulated by the strategic activities of leading companies based in the region, such as Mindray, Baxter, and Becton, Dickinson and Company. These firms play a critical role in the sector's growth through continuous innovation and new product offerings. For instance, in February 2023, Mindray launched its BeneFusion i and u Series infusion systems, which are notable for their high precision and user-friendly design. Featuring an intuitive full touch screen and a flat design that highlights essential parameters, the BeneFusion series enhances visibility and usability for medical staff, allowing for safer and more precise operations.

The convergence of these factors, along with ongoing product launches and regulatory approvals, underscores the significant role North America will continue to play in driving the growth of the global Infusion Therapy Devices market from 2024 to 2030.

Infusion Therapy Devices Market Key Players:

Some of the key market players operating in the Infusion Therapy Devices Market include Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy., Smiths Group plc., B. Braun SE, Trivitron Healthcare, Eitan Medical, and Others.

Recent Developmental Activities In The Infusion Therapy Devices Market:

  • In August 2021, Baxter got the approval of U.S. Food Drug Administration (FDA) 510 (k) clearance for its Novum IQ syringe infusion pump.
  • In January 2022, ICU Medical Inc. finalized the acquisition of Smiths Medical from Smiths Group plc. This strategic move brings together a comprehensive portfolio encompassing syringe infusion devices, ambulatory infusion devices, vascular access solutions, and vital care products. By integrating the ambulatory infusion devices and vascular access offerings from Smiths Group plc with ICU Medical's Vital care products, the newly formed entity emerges as a prominent player in the infusion therapy sector, poised to exert a significant global presence.

Key Takeaways From The Infusion Therapy Devices Market Report Study

  • Market size analysis for current Infusion Therapy Devices market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Infusion Therapy Devices market.
  • Various opportunities are available for the other competitors in the Infusion Therapy Devices market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030.
  • Which are the top-performing regions and countries in the current Infusion Therapy Devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Infusion Therapy Devices market growth in the coming future?

Target Audience Who Can Be Benefited From This Infusion Therapy Device Market Report Study

  • Infusion Therapy Devices product providers
  • Research organizations and consulting companies
  • Infusion Therapy Devices organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in Infusion Therapy Devices
  • Various end-users who want to know more about the infusion therapy device market and the latest innovations and developments in the infusion therapy device market.

Frequently Asked Questions For The Infusion Therapy Devices Market

1. What are Infusion Therapy Devices?

An infusion pump is a medical device utilized to administer fluids, including nutrients and medications, into a patient's body with precise control over the dosage. Widely employed across various clinical environments such as hospitals, nursing homes, and home care settings, these devices play a crucial role in medical treatment.

2. What is the market for global Infusion Therapy Devices?

The global Infusion Therapy Devices market is estimated to grow at a CAGR of 6.56% during the forecast period from 2024 to 2030 to reach USD 77.65 billion by 2030.

3. What are the drivers for the global infusion therapy devices market?

The surge in demand for Infusion Therapy Devices is predominantly driven by critical factors such as the escalating prevalence of chronic disorders like diabetes and cancer. With infusion therapy devices encompassing a broad spectrum of clinical treatments, coupled with a notable increase in product launches, the market is experiencing a significant upswing. These factors collectively contribute to fostering a positive trajectory for the growth of the infusion therapy device market throughout the forecast period spanning from 2024 to 2030.

4. Who are the key players operating in the global infusion therapy devices market?

Some of the key market players operating in the Infusion Therapy Devices market include Fresenius Kabi AG, Ossila, Ace-medical, ICU Medical, Chmyx Inc., Mindray, Baxter, Becton, Dickinson and Company, Micrel Medical Devices SA, AKAS Infusions, Narang Medical Limited, Monidor Oy., Smiths Group plc., B. Braun SE, Trivitron Healthcare, Eitan Medical, and others.

5. Which region has the highest share in the infusion therapy devices market?

North America is projected to dominate the Infusion Therapy Devices market in 2023, buoyed by its advanced healthcare infrastructure and a high incidence of chronic diseases such as diabetes, cancer, and arthritis. The region's robust growth is further supported by continual technological advancements, the presence of major industry players, and a dynamic market environment conducive to product development and launches.

Table of Contents

1. Infusion Therapy Devices Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Infusion Therapy Devices Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Infusion Therapy Devices Market Key Factors Analysis

  • 5.1. Infusion Therapy Devices Market Drivers
    • 5.1.1. Growing prevalence of Diabetes and other Chronic diseases
    • 5.1.2. Growing geriatric population
  • 5.2. Infusion Therapy Devices Market Restraints and Challenges
    • 5.2.1. High Cost of Infusion Therapy Devices
    • 5.2.2. Risk of developing infections while using infusion therapy device
  • 5.3. Infusion Therapy Devices Market Opportunity
    • 5.3.1. Advancing smart technologies like- real-time monitoring, connectivity, and personalized treatment plans.

6. Infusion Therapy Devices Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes s
  • 6.5. Competitive Rivalry

7. Infusion Therapy Devices Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Syringe Infusion Pumps
    • 7.1.2. Large Volume Pumps (LVP)
    • 7.1.3. Elastomeric Pumps
    • 7.1.4. Others
  • 7.2. By Mobility
    • 7.2.1. Portable Infusion Pumps
    • 7.2.2. Stationary Infusion Pumps
  • 7.3. By Application
    • 7.3.1. Multiple Sclerosis
    • 7.3.2. Diabetes
    • 7.3.3. Rheumatoid Arthritis
    • 7.3.4. Cancer
    • 7.3.5. Others
  • 7.4. End-User
    • 7.4.1. Hospitals and Clinics
    • 7.4.2. Ambulatory Surgical Centers
    • 7.4.3. Homecare
    • 7.4.4. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.5. Spain Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.3. India Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Infusion Therapy Devices Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Infusion Therapy Devices Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Infusion Therapy Devices Market Size in USD million (2021-2030)

8. Infusion Therapy Devices Market Company and Product Profiles

  • 8.1. Fresenius Kabi AG
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Ossila
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Ace-medical
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. ICU Medical
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Chmyx inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Mindray
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Baxter
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Becton, Dickinson and Company
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Micrel Medical Devices SA
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. AKAS Infusions
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Narang Medical Limited
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Monidor Oy.
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Smiths Group plc.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. B. Braun SE
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Trivitron Healthcare
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Eitan Medical
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Infusion Therapy Devices Market in Global (2021-2030)
  • Table 3: Infusion Therapy Devices Market in Global by Product Type (2021-2030)
  • Table 4: Infusion Therapy Devices Market in Global by Mobility (2021-2030)
  • Table 5: Infusion Therapy Devices Market in Global by Application (2021-2030)
  • Table 6: Infusion Therapy Devices Market in Global by End-User (2021-2030)
  • Table 7: Infusion Therapy Devices Market in Global by Geography (2021-2030)
  • Table 8: Infusion Therapy Devices Market in North America (2021-2030)
  • Table 9: Infusion Therapy Devices Market in North America by Country (2021-2030)
  • Table 10: Infusion Therapy Devices Market in the US (2021-2030)
  • Table 11: Infusion Therapy Devices Market in Canada (2021-2030)
  • Table 12: Infusion Therapy Devices Market in Mexico (2021-2030)
  • Table 13: Infusion Therapy Devices Market in Europe (2021-2030)
  • Table 14: Infusion Therapy Devices Market in Europe by Country (2021-2030)
  • Table 15: Infusion Therapy Devices Market in France (2021-2030)
  • Table 16: Infusion Therapy Devices Market in Germany (2021-2030)
  • Table 17: Infusion Therapy Devices Market in the United Kingdom (2021-2030)
  • Table 18: Infusion Therapy Devices Market in Italy (2021-2030)
  • Table 19: Infusion Therapy Devices Market in Spain (2021-2030)
  • Table 20: Infusion Therapy Devices Market in the Rest of Europe (2021-2030)
  • Table 21: Infusion Therapy Devices Market in Asia-Pacific (2021-2030)
  • Table 22: Infusion Therapy Devices Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Infusion Therapy Devices Market in China (2021-2030)
  • Table 24: Infusion Therapy Devices Market in Japan (2021-2030)
  • Table 25: Infusion Therapy Devices Market in India (2021-2030)
  • Table 26: Infusion Therapy Devices Market in Australia (2021-2030)
  • Table 27: Infusion Therapy Devices Market in South Korea (2021-2030)
  • Table 28: Infusion Therapy Devices Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Infusion Therapy Devices Market in the Rest of the World (2021-2030)
  • Table 30: Infusion Therapy Devices Market in the Middle East (2021-2030)
  • Table 31: Infusion Therapy Devices Market in Africa (2021-2030)
  • Table 32: Infusion Therapy Devices Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Infusion Therapy Devices Market in Global (2021-2030)
  • Figure 3: Infusion Therapy Devices Market in Global by Product Type (2021-2030)
  • Figure 4: Infusion Therapy Devices Market in Global by Mobility (2021-2030)
  • Figure 5: Infusion Therapy Devices Market in Global by Application (2021-2030)
  • Figure 6: Infusion Therapy Devices Market in Global by End-User (2021-2030)
  • Figure 7: Infusion Therapy Devices Market in Global by Geography (2021-2030)
  • Figure 8: Infusion Therapy Devices Market in North America (2021-2030)
  • Figure 9: Infusion Therapy Devices Market in North America by Country (2021-2030)
  • Figure 10: Infusion Therapy Devices Market in the US (2021-2030)
  • Figure 11: Infusion Therapy Devices Market in Canada (2021-2030)
  • Figure 12: Infusion Therapy Devices Market in Mexico (2021-2030)
  • Figure 13: Infusion Therapy Devices Market in Europe (2021-2030)
  • Figure 14: Infusion Therapy Devices Market in Europe by Country (2021-2030)
  • Figure 15: Infusion Therapy Devices Market in France (2021-2030)
  • Figure 16: Infusion Therapy Devices Market in Germany (2021-2030)
  • Figure 17: Infusion Therapy Devices Market in the United Kingdom (2021-2030)
  • Figure 18: Infusion Therapy Devices Market in Italy (2021-2030)
  • Figure 19: Infusion Therapy Devices Market in Spain (2021-2030)
  • Figure 20: Infusion Therapy Devices Market in the Rest of Europe (2021-2030)
  • Figure 21: Infusion Therapy Devices Market in Asia-Pacific (2021-2030)
  • Figure 22: Infusion Therapy Devices Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Infusion Therapy Devices Market in China (2021-2030)
  • Figure 24: Infusion Therapy Devices Market in Japan (2021-2030)
  • Figure 25: Infusion Therapy Devices Market in India (2021-2030)
  • Figure 26: Infusion Therapy Devices Market in Australia (2021-2030)
  • Figure 27: Infusion Therapy Devices Market in South Korea (2021-2030)
  • Figure 28: Infusion Therapy Devices Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Infusion Therapy Devices Market in the Rest of the World (2021-2030)
  • Figure 30: Infusion Therapy Devices Market in the Middle East (2021-2030)
  • Figure 31: Infusion Therapy Devices Market in Africa (2021-2030)
  • Figure 32: Infusion Therapy Devices Market in South America (2021-2030)
  • Figure 33: Market Drivers
  • Figure 34: Market Barriers
  • Figure 35: Marker Opportunities
  • Figure 36: PORTER'S Five Force Analysis